ProfileGDS5822 / ILMN_1243099
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 73% 77% 77% 72% 76% 77% 82% 73% 73% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 164.673
GSM1276600PDAC Late Ablation Control 2112.277
GSM1276601PDAC Late Ablation Control 3141.977
GSM1276602PDAC Late Ablation 157.372
GSM1276603PDAC Late Ablation 299.676
GSM1276604PDAC Late Ablation 3113.677
GSM1303940PDAC Late Ablation_anti-CTLA4 1161.182
GSM1303941PDAC Late Ablation_anti-CTLA4 287.773
GSM1303942PDAC Late Ablation_anti-CTLA4 389.573